Beneficial behavioral effects of chronic cerebral dopamine neurotrophic factor (CDNF) infusion in the N171-82Q transgenic model of Huntington’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Beneficial behavioral effects of chronic cerebral dopamine neurotrophic factor (CDNF) infusion in the N171-82Q transgenic model of Huntington’s disease ; volume:13 ; number:1 ; day:20 ; month:2 ; year:2023 ; pages:1-17 ; date:12.2023
Scientific reports ; 13, Heft 1 (20.2.2023), 1-17, 12.2023
- Creator
-
Stepanova, P.
Kumar, D.
Cavonius, K.
Korpikoski, J.
Sirjala, J.
Lindholm, D.
Voutilainen, M. H.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-28798-4
- URN
-
urn:nbn:de:101:1-2023042621091570404706
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.12.2025, 9:51 AM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Stepanova, P.
- Kumar, D.
- Cavonius, K.
- Korpikoski, J.
- Sirjala, J.
- Lindholm, D.
- Voutilainen, M. H.
- SpringerLink (Online service)
Other Objects (12)
Cerebral dopamine neurotrophic factor (CDNF) protects against quinolinic acid-induced toxicity in in vitro and in vivo models of Huntington’s disease
Huntington
Huntington's chorea
Chorea Huntington
Huntington-Erkrankung
Nucleolar stress controls mutant Huntington toxicity and monitors Huntington’s disease progression
Targeting Huntington’s disease through histone deacetylases
Cardiac autonomic involvement in Huntington’s disease
Treatment of Irritability in Huntington’s Disease
G3 Hedonic olfaction in huntington’s disease
Economic burden of Huntington’s disease in Peru
Pulmonary function in patients with Huntington’s Disease
Cerebral dopamine neurotrophic factor (CDNF) protects against quinolinic acid-induced toxicity in in vitro and in vivo models of Huntington’s disease
Huntington
Huntington's chorea
Chorea Huntington
Huntington-Erkrankung
Nucleolar stress controls mutant Huntington toxicity and monitors Huntington’s disease progression
Targeting Huntington’s disease through histone deacetylases
Cardiac autonomic involvement in Huntington’s disease
Treatment of Irritability in Huntington’s Disease
G3 Hedonic olfaction in huntington’s disease
Economic burden of Huntington’s disease in Peru
Pulmonary function in patients with Huntington’s Disease
Cerebral dopamine neurotrophic factor (CDNF) protects against quinolinic acid-induced toxicity in in vitro and in vivo models of Huntington’s disease
Huntington
Huntington's chorea
Chorea Huntington
Huntington-Erkrankung
Nucleolar stress controls mutant Huntington toxicity and monitors Huntington’s disease progression
Targeting Huntington’s disease through histone deacetylases
Cardiac autonomic involvement in Huntington’s disease
Treatment of Irritability in Huntington’s Disease
G3 Hedonic olfaction in huntington’s disease
Economic burden of Huntington’s disease in Peru